Transcode Therapeutics Inc
关键数据
5.130今开
5.370最高
30.26K成交量
亏损市盈率 TTM
--市盈率动
--股息TTM
3.63%换手率
5.250昨收
4.470最低
69.04K成交额
亏损市盈率静
2.78市净率
0.00%股息率 TTM
-47.38%ROA
20.99052周最高
1.42量比
-16.82M净利润
833.68K总股本
-3.7086每股收益TTM
1.32Beta
-757.04%ROE
5.01052周最低
17.14%振幅
--毛利率
3.96M总市值
-6.35回报/风险
6.14%风险率
Transcode Therapeutics Inc新闻
即将为您带来更多新闻,敬请期待。。。
收益预测
Transcode Therapeutics Inc
RNAZ
0
Ionis Pharmaceuticals Inc
IONS
25
技术指标
财务指标
每股收益

由于公司未披露,未能获取相关数据
营业总收入

由于公司未披露,未能获取相关数据
Transcode Therapeutics Inc简介
TransCode Therapeutics, Inc. is a clinical-stage oncology company focused on treating metastatic disease. It is defeating cancer through the intelligent design and effective delivery of RNA therapeutics based on its proprietary TTX nanoparticle platform. Its lead candidate, TTX-MC138, targets metastatic tumors overexpressing microRNA-10b, a biomarker of metastasis. The Company is also developing a portfolio of RNA therapeutic candidates to overcome delivery challenges and unlock access to novel genetic targets. Its preclinical programs include TTX-siPDL1 (siRNA modulator of PD-L1), TTX-RIGA (RNA agonist of RIG-I for innate immunity activation), and TTX-siMYC (siRNA inhibitor of c-MYC). Additionally, R&D efforts are exploring the combination of TTX-MC138 and seviprotimut-L technologies to enhance therapeutic impact.
公司代码RNAZ
公司Transcode Therapeutics Inc
CEOCalais (Philippe P)
网址https://www.transcodetherapeutics.com/
公司股东
常见问题
Transcode Therapeutics Inc(RNAZ)的当前股价是多少?
Transcode Therapeutics Inc(RNAZ)的当前股价是 4.75。
Transcode Therapeutics Inc的股票代码是什么?
Transcode Therapeutics Inc的股票代码是RNAZ。
Transcode Therapeutics Inc股票的52周最高点是多少?
Transcode Therapeutics Inc股票的52周最高点是20.99。
Transcode Therapeutics Inc股票的52周最低点是多少?
Transcode Therapeutics Inc股票的52周最低点是5.01。
Transcode Therapeutics Inc的市值是多少?
Transcode Therapeutics Inc的市值是3.96M。
Transcode Therapeutics Inc(RNAZ)股票的每股收益(EPS TTM)是多少
Transcode Therapeutics Inc(RNAZ)股票的每股收益(EPS TTM)是-52.59。